0001564590-21-054505 | 10-Q | XBRL Viewer | Treace Medical Concepts INC

Label	Element	Value
Accrued Expenses	tmci_AccruedExpenses	$ 797,000
Accrued Expenses	tmci_AccruedExpenses	565,000
Decrease In Depreciation Expense	tmci_DecreaseInDepreciationExpense	100,000
Decrease In Depreciation Expense	tmci_DecreaseInDepreciationExpense	100,000
Decrease In Depreciation Expense	tmci_DecreaseInDepreciationExpense	$ 200,000
Operating Lease Year Of Expiration	tmci_OperatingLeaseYearOfExpiration	2026
Stock Issued During Period Value Warrants Exercised	tmci_StockIssuedDuringPeriodValueWarrantsExercised	$ 1,000
Stock Issued During Period Value Warrants Exercised	tmci_StockIssuedDuringPeriodValueWarrantsExercised	$ (1,000)
Stock Issued During Period Shares Conversion And Accrued Dividends Of Convertible Securities	tmci_StockIssuedDuringPeriodSharesConversionAndAccruedDividendsOfConvertibleSecurities	(6,687,475)
Stock Issued During Period Shares Conversion And Accrued Dividends Of Convertible Securities	tmci_StockIssuedDuringPeriodSharesConversionAndAccruedDividendsOfConvertibleSecurities	6,845,922
Conversion Of Convertible Preferred Stock And Accrued Dividends On Convertible Preferred Stock Into Common Stock	tmci_ConversionOfConvertiblePreferredStockAndAccruedDividendsOnConvertiblePreferredStockIntoCommonStock	$ 7,935,000
Share Based Compensation By Share Based Payment Arrangement Shares Available For Grant Granted	tmci_ShareBasedCompensationByShareBasedPaymentArrangementSharesAvailableForGrantGranted	1,787,761
Issuance Cost And Underwriting Discount	tmci_IssuanceCostAndUnderwritingDiscount	$ 10,600,000
Proceeds From Interest Bearing Debt	tmci_ProceedsFromInterestBearingDebt	29,530,000
Proceeds From Initial Public Offering Used To Offset Offering Costs	tmci_ProceedsFromInitialPublicOfferingUsedToOffsetOfferingCosts	$ 2,300,000
Stock Issued During The Period Shares Including Sale By The Existing Shareholders	tmci_StockIssuedDuringThePeriodSharesIncludingSaleByTheExistingShareholders	12,937,500
Payments On Interest Bearing Debt	tmci_PaymentsOnInterestBearingDebt	$ 20,000,000
Stock Issued During Period Value Conversion And Accrued Dividends Of Convertible Securities	tmci_StockIssuedDuringPeriodValueConversionAndAccruedDividendsOfConvertibleSecurities	(7,935,000)
Stock Issued During Period Value Conversion And Accrued Dividends Of Convertible Securities	tmci_StockIssuedDuringPeriodValueConversionAndAccruedDividendsOfConvertibleSecurities	7,000
Stock Issued During Period Value Conversion And Accrued Dividends Of Convertible Securities	tmci_StockIssuedDuringPeriodValueConversionAndAccruedDividendsOfConvertibleSecurities	$ 7,928,000
Stock Issued During Period Shares Warrant Exercised	tmci_StockIssuedDuringPeriodSharesWarrantExercised	621,570
Accrued Commissions	tmci_AccruedCommissions	$ 3,021,000
Accrued Commissions	tmci_AccruedCommissions	$ 3,513,000
Sale Of Stock By The Existing Shareholders	tmci_SaleOfStockByTheExistingShareholders	5,984,375
Sale Of Stock By The Existing Shareholders	tmci_SaleOfStockByTheExistingShareholders	984,375
Operating Lease Future Minimum Payments Due Year Five And Thereafter	tmci_OperatingLeaseFutureMinimumPaymentsDueYearFiveAndThereafter	$ 1,275,000
Share Based Compensation By Share Based Payment Arrangement Shares Available For Grant Cancelled	tmci_ShareBasedCompensationByShareBasedPaymentArrangementSharesAvailableForGrantCancelled	48,782
Forward Stock Split [Member]
Shares Authorized Preferred And Common Stock	tmci_SharesAuthorizedPreferredAndCommonStock	73,562,500
Royalty Agreement With Certain Members Of The Surgeon Advisory Board [Member]
Period Over Which The Royalties Are Payable	tmci_PeriodOverWhichTheRoyaltiesArePayable	3 years
Period Over Which The Royalties Are Payable	tmci_PeriodOverWhichTheRoyaltiesArePayable	3 years
Notice Period For Termination Of Agreement	tmci_NoticePeriodForTerminationOfAgreement	90 days
Notice Period For Termination Of Agreement	tmci_NoticePeriodForTerminationOfAgreement	90 days

Stockholders' Equity - Summary of the Company had Reserved Shares of Common Stock for Future Issuances (Detail)	Sep. 30, 2021 shares
Shares Reserved For Future Issuance [Line Items]
Common stock available for future issuances	238,366,816

Print Document View Excel Document
Notes Details Stockholders' Equity - Summary of the Company had Reserved Shares of Common Stock for Future Issuances (Detail) Uncategorized Uncategorized Items - tmci-10q_20210930_htm.xml All Reports